800 BRIDGE PARKWAY, REDWOOD CITY, CA
Provides Second Quarter 2025 Financial Results and Business Highlights
Shareholder votes
Announces New Positive Data for Its iMMagine-1 Study in Patients with Relapsed and/or Refractory Multiple Myeloma
Provides First Quarter 2025 Financial Results and Business Highlights
Annual Report to Security Holders
Appoints Andrew Galligan and Kristin Myers to its Board of Directors
Earnings Release
Investor Presentation
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
S-3ASR
Notice of Exempt Offering of Securities
Effectiveness Notice
Prospectus filed pursuant to Rule 424(b)(4)
Amended Registration Statement for Securities
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities